Monday, October 26, 2026 · Daily editionET --:--:--

Looking for volunteers

Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease

NCT07178210 · MMI (Medical Microinstruments, Inc.) · Updated 24 Aug 2026

What is being tested
Symani Surgical System
For
Alzheimer Disease; Lymphatic Obstruction
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 50 years and older. About 15 people. The full rules are on the registry page.
Where
United States (3 sites)
When
Starts or started 30 April 2026, ends 30 Oct 2027. Registered 17 Sept 2025.
Results
None posted yet.

In the researchers' words

The objective of this investigational device exemption (IDE) study is to evaluate the safety and feasibility of using the Symani System and microsurgical techniques in the deep cervical lymph node (dCLN) region in the setting of mild to moderate Alzheimer's disease and lymphatic abnormalities.
ClinicalTrials.gov, NCT07178210

Sites

  • Stanford Medical CenterPalo Alto, California, United States
  • Baptist Health Research InstituteJacksonville, Florida, United States
  • The Research Foundation for State University of New YorkBuffalo, New York, United States